<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04417881</url>
  </required_header>
  <id_info>
    <org_study_id>7880</org_study_id>
    <nct_id>NCT04417881</nct_id>
  </id_info>
  <brief_title>EVALUATION OF THE MEESSI SCORE FOR RISK STRATIFICATION OF PATIENTS ADMITTED FOR ACUTE HEART FAILURE IN EMERGENCY DEPARTMENTS</brief_title>
  <acronym>CAMEESSI</acronym>
  <official_title>EVALUATION OF THE MEESSI SCORE FOR RISK STRATIFICATION OF PATIENTS ADMITTED FOR ACUTE HEART FAILURE IN EMERGENCY DEPARTMENTS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our primary purpose is to assess MEESSI score in predicting mortality and readmission of
      patients managed for acute heart failure (AHF) in Emergency Department.

      European Society of Cardiology recommend risk stratification for patients with AHF. MEESSI
      score is not prospectively validated out of Spain.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MEESSI score</measure>
    <time_frame>30 days</time_frame>
    <description>The primary endpoint is a composite endpoint: all-cause mortality and readmission at 30 days. This rate, expressed as a percentage, is compared between the 4 risk categories defined by the MEESSI score.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Re-admission rate</measure>
    <time_frame>30 days</time_frame>
    <description>30-day re-admission rate compared between the 4 risk categories defined by the MEESSI score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>30 days</time_frame>
    <description>Mortality rate at 30 days compared between the 4 risk categories defined by the MEESSI score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity</measure>
    <time_frame>30 days</time_frame>
    <description>Sensitivity, specificity and ROC curve of the MEESSI score in relation to the composite criterion according to the 4 risk categories</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">443</enrollment>
  <condition>Acurate Heart Failure</condition>
  <arm_group>
    <arm_group_label>patients with acurate heart failure</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MEESSI score</intervention_name>
    <description>MEESSI score in predicting mortality and readmission of patients managed for acute heart failure (AHF) in Emergency Department.</description>
    <arm_group_label>patients with acurate heart failure</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient admitted to emergencies with suspicion of ICA
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major patient

          -  Patient admitted to emergencies with suspicion of ICA according to the clinical
             intuition of the emergency doctor after interrogation, clinical examination, biology
             and imaging

          -  Patient with health insurance

          -  Subject who accept to participate in the research

        Exclusion Criteria:

          -  Patient who refuse to participate in the study

          -  Patient with coronary syndrome with ST segment elevation

          -  Other diagnosis of dyspnea

          -  Persons deprived of their freedom or under the protection of justice

          -  Persons under guardianship or curatorship

          -  Impossibility of giving the patient informed information

          -  Pregnant woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hôpital Jean Minjoz</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Thibaut DESMETTRE</last_name>
      <phone>+33 3 81 66 88 37</phone>
      <email>tdesmettre@chu-besancon.fr</email>
    </contact>
    <investigator>
      <last_name>Thibaut DESMETTRE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Jean Rougié</name>
      <address>
        <city>Cahors</city>
        <zip>46005</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Duc-Minh TRAN</last_name>
      <phone>+33 5 65 20 54 41</phone>
      <email>Ducminh.tran@hotmail.fr</email>
    </contact>
    <investigator>
      <last_name>Duc-Minh TRAN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Civils de Colmar</name>
      <address>
        <city>Colmar</city>
        <zip>68000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Yannick GOTTWALLES</last_name>
      <phone>+33 3 89 12 40 96</phone>
      <email>yannick.gottwalles@ch-colmar.fr</email>
    </contact>
    <investigator>
      <last_name>Yannick GOTTWALLES</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Haguenau</name>
      <address>
        <city>Haguenau</city>
        <zip>67500</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Lise BERRARD</last_name>
      <phone>+33 3 88 06 30 57</phone>
      <email>Lise.Berard@ch-haguenau.fr</email>
    </contact>
    <investigator>
      <last_name>Lise BERRARD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Forez</name>
      <address>
        <city>Montbrison</city>
        <zip>42605</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Mikael MARTINEZ</last_name>
      <phone>+33 4 77 96 78 38</phone>
      <email>Mikael.martinez@ch-forez.fr</email>
    </contact>
    <investigator>
      <last_name>Mikael MARTINEZ</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Bruno LEHODEY</last_name>
      <phone>+33 4 67 33 67 33</phone>
      <email>b-lehodey@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Bruno LEHODEY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54035</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Tahar CHOUIHED</last_name>
      <phone>+ 33 3 83 85 14 96</phone>
      <email>t.chouihed@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Tahar CHOUIHED</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Pitié Salpetrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Quentin DELANOY</last_name>
      <phone>+33 1 42 16 00 00</phone>
      <email>yonatman@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Quentin DELANOY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Reims</name>
      <address>
        <city>Reims</city>
        <zip>51100</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Stephane GENNAI</last_name>
      <phone>+33 3 26 78 76 02</phone>
      <email>sgennai@chu-reims.fr</email>
    </contact>
    <investigator>
      <last_name>Stephane GENNAI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Remiremont</name>
      <address>
        <city>Remiremont</city>
        <zip>88200</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Marie Paule BITAR</last_name>
      <phone>+33 3 29 23 40 64</phone>
      <email>Mariepaule.bitar@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Marie Paule BITAR</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Robert Pax</name>
      <address>
        <city>Sarreguemines</city>
        <zip>57200</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Emmanuelle SERIS</last_name>
      <phone>+33 3 87 27 34 66</phone>
      <email>emmanuelle.seris@ch-sarreguemines.fr</email>
    </contact>
    <investigator>
      <last_name>Emmanuelle SERIS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Les Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Mathieu OBERLIN</last_name>
      <phone>+33 3 69 55 05 61</phone>
      <email>Mathieu.oberlin@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Mathieu OBERLIN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31300</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Frederic BALEN</last_name>
      <phone>+33 5 61 77 20 18</phone>
      <email>balen.f@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Frederic BALEN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord Franche Comté</name>
      <address>
        <city>Trévenans</city>
        <zip>90400</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Charles Eric LAVOIGNET</last_name>
      <phone>+33 3 84 98 33 97</phone>
      <email>Charles-Eric.lavoignet@hnfc.fr</email>
    </contact>
    <investigator>
      <last_name>Charles Eric LAVOIGNET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 2, 2020</study_first_submitted>
  <study_first_submitted_qc>June 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 5, 2020</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>caring</keyword>
  <keyword>emergency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

